Latest Content
Operationalizing genomic epidemiology during the Nord Kivu Ebola outbreak, Democratic Republic of Congo
In July 2018, the National Biomedical Research Institute (INRB), in the Democratic Republic of Congo (DRC), set up a pathogen genomics laboratory which allowed us to confirm epidemics of Ebola Virus Disease in the country and to establish epidemiological links between confirmed cases (1-3).
A biomarker study informs the clinical development of novel strategies: the unanticipated impact of the ANTICIPATE study
“Our compound neutralizes antibiotics in the large intestines and prevents gut microbiota disruption. Could we collaborate on its clinical development?” That was the question that brought the French biotech company Da Volterra into COMBACTE.
Featured Contributors
Behind the paper
Share the real story behind your paper, from conception to publication, the highs and the lows.
After the Paper
What happened after your paper was published - and what impact did it have on your career?
Starting a new face: from biochemistry to the biology of biofilms
After working with bacterial biofilms as model to understand the evolution of enzymes in complex environments, it was hard to go back to domesticated bacteria. In my new lab we will continue to bridge between biofilms' biology and evolutionary biochemistry.
Coronaviruses: past, present and future
Share your research, thoughts and experience on the coronavirus family.
About the Community
Community updates, top tips and highlighted content.Welcome to our new home
From the editors
News, policy and social updates from the editors of Nature Microbiology and microbiology editors of other Nature titles
On the road
Conferences, lab visits, vacations. Hear all about our editors travels and tell us about yours.
Probiotics, microbiota and human health: Sifting hope from hype
A report on the 10th India Probiotic Symposium: Cutting-edge science and applications: Intestinal microbiota and probiotics. February 29 – March 1, 2020, New Delhi, India.
